"CGT Global is on a mission to transform the life science and medical industries. Our commitment is to expedite research, accelerate clinical trials, streamline the commercialization process, and broaden patient access to life-changing therapies" Cate Spears, Founder and CEO
We are CGT Global
We’re not just supplying the starting materials for cell and gene therapy.
We’re building the foundation for research, for access, and for the clinics of tomorrow.
From discovery to commercialization, CGT Global supports the world’s leading researchers with ethically sourced, high-quality human blood and bone marrow products — collected, processed, and delivered with unmatched care.
CGT Global in the News
Trusted Leadership Driving Innovation in Oncology and Rare Disease
Clinical development in oncology and rare diseases is becoming increasingly complex. Success depends on expertly navigating evolving regulatory pathways and overcoming unique challenges at every stage. At CGT Global, our leadership team combines decades of deep expertise in these specialized fields to guide your program with precision and insight.
Our experience in managing complex indications accelerates milestone achievement, drives positive clinical outcomes, and—most importantly—helps patients gain access to breakthrough therapies. With CGT Global as your partner, you benefit from a leadership team dedicated to advancing innovation and delivering reliable, tailored support throughout your cell and gene therapy journey.
Specialized Capabilities for Every Stage of Cell & Gene Therapy Development
Leverage CGT Global’s integrated donor-to-delivery infrastructure to eliminate inefficiencies and accelerate progress. Our coordinated approach connects biospecimen sourcing, specialty lab services, and clinical trial support—streamlining your path from discovery to commercialization.
Driving Discovery for a Healthier Tomorrow
At CGT Global, we’re proud to contribute to a field that has the power to transform lives. Sharing expertise and data enhances our collective progress—together, we amplify innovation. By fostering collaboration and open exchange, we accelerate the journey from breakthrough science to accessible therapies, bringing new hope to patients everywhere.